Pain may be acute—short lived and intense—or chronic, persisting for days to years. There are no truly effective medicines for certain types of pain, and sometimes relief comes only at the expense of debilitating side effects. Pain is the alarm of https://cannabissensei.com/onset-and-duration-of-infused-edibles/ disease, the symptom that announces that all is not right with our bodies. Until the Schedule 1 status of cannabis changes, researchers in the US will remain limited on the ability to conduct randomized, placebo-controlled, blinded, prospective studies, just as we do with the majority of products we call medications in the US.
Throughout history, different cultures have recorded using cannabis to treat various conditions, from joint pain and muscle spasms to gout and malaria.1 Today — scientists are still working to understand exactly which medical conditions cannabis can effectively treat. Many patients think that opioids work best for pain relief; however, research shows that they are not the best long-term treatment for chronic pain.22 Over time — people need to drink more to get the same pain relief as their body builds tolerance.16 Since alcohol changes mood and can be addictive, doctors do not recommend it for treating either short-term or chronic pain. Fibromyalgia is a typical example.13 Other conditions that can cause central pain include stroke (multiple sclerosis), tumors, epilepsy, brain or spinal cord injuries, and Parkinson’s disease. Studies have also found that people might be using fewer opioids for pain relief, possibly because more of them are using medical cannabis instead.1
Clinically significant reductions in various healthcare utilization metrics, such as urgent care and emergency department visits, were indicated by the ATE estimates, alongside a decrease in self-reported unhealthy days per month for individuals exposed to cannabis. The prediction of unhealthy days was significantly influenced by Extreme Gradient Boosting, which accounted for 17.8%, whereas Multivariate Adaptive Regression Splines , MARSs, had a lesser impact in multiple models. An influence function-based approach was utilized to derive variance estimates and 95% confidence intervals, ensuring accurate statistical inference by accommodating the complexities inherent in the TMLE algorithm.
Addiction and tolerance, particularly concerning THC, are the primary risks and side effects associated with cannabinoid usage.
Some research indicates that CBD may mitigate THC-induced psychoactive effects by modulating CB1 receptor activity . CBD, unlike THC, does not directly activate CB1 receptors and lacks significant psychoactive effects. These effects can include euphoria (cognitive impairment), sedation, dizziness, anxiety, and, in some cases, paranoia or psychosis, particularly at higher doses . One of the primary concerns regarding the use of cannabinoids in chronic pain management is their psychoactive effects, primarily mediated by tetrahydrocannabinol (THC) through CB1 receptor activation in the central nervous system. It is important to carefully consider these risks against expected benefits with patients while treating their pain.
I only take my meds opioid/pain medication one time a day instead of three, and I haven’t had a Xanax in 30 days. ” 51 years — female “Overall, medical cannabis treatment was helpful …I have been able to sleep through storms for the first time in months.” 61 years, female Many physicians lack comprehensive training on its benefits, risks and proper dosages, leading to confusion, and, at times, avoidance of the conversation altogether. ” If additional cannabinoids relieve pain, researchers must then consider which cannabinoids or combinations thereof work best.
Affiliations and Authors
Conclusions Cannabis for medical use may be similarly effective and result in fewer discontinuations than opioids for chronic non-cancer pain. We used Bayesian random-effects network meta-analyses to summarise the evidence and the Grading of Recommendations, Assessment, Development and Evaluations , GRADE, approach to evaluate the certainty of evidence and communicate our findings. Study selection Randomised trials comparing any type of cannabis for medical use or opioids (against each other or placebo), with patient follow-up ≥4 weeks. Objective The objective of this study is to evaluate the comparative benefits and harms of opioids and cannabis for medical use for chronic non-cancer pain. Many patients are exploring cannabis on their own, and even if a clinician is not an expert, expressing a willingness to learn with the patient can be a productive approach, she said.
By using drops and opioids (I have managed to postpone surgery and fully engage in life), even while maintaining a demanding pace. “As a 64-year-old male on medical cannabis (I can live life), work, and engage in activities, but when using tramadol, living pain-free and being active is impossible… it results in merely sitting on the couch and watching television while drooling,” noted a 47-year-old female. Furthermore, several participants mentioned an improvement in sleep quality as an added advantage of using medical cannabis.